Showing 2531-2540 of 3223 results for "".
- Scientists Develop Therapeutic Model for Potentially Treating Incurable Eye Diseaseshttps://modernod.com/news/scientists-develop-therapeutic-model-for-potentially-treating-incurable-eye-diseases/2481794/Researchers have successfully transplanted human microglia cells into mouse retina to create a model that could be used to test new treatments for retinal and central nervous system diseases, according to not-for-profit eLife. Microglia are the innate immune cells of the cent
- Apellis Provides Update on Review of Safety Events with Syfovre for Geographic Atrophyhttps://modernod.com/news/apellis-provides-update-on-review-of-safety-events-with-syfovre-for-geographic-atrophy/2481755/Apellis Pharmaceuticals provided an update on its review of rare events of retinal vasculitis reported in real-world treatment with Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). “The safety of patients has always
- Smartlens Closes $6.1 Million Series A Financing to Advance miLens Devicehttps://modernod.com/news/smartlens-closes-61-million-series-a-financing-to-advance-milens/2481727/Smartlens has closed an oversubscribed $6.1 million Series A equity financing round to advance regulatory clearance for miLens, a novel, electronics-free, soft contact lens for monitoring diurnal IOP. The miLens device is an electronics free soft contact lens that uses mi
- Study: Low-Dose Atropine Eye Drops No Better than Placebo for Slowing Myopia Progressionhttps://modernod.com/news/study-low-dose-atropine-eye-drops-no-better-than-placebo-for-slowing-myopia-progression/2481725/A trial conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and funded by the National Eye Institute (NEI) showed that use of low-dose atropine eye drops (concentration 0.01%) was no better than placebo at slowing myopia progression and elongation of the eye among children trea
- Dean Burns Named President and CEO of Ocumeticshttps://modernod.com/news/dean-burns-named-president-and-ceo-of-ocumetics/2481722/Ocumetics Technology has appointed ophthalmic executive Dean Burns as President and CEO. Mr. Burns, whoj will also join the Ocumetics board of directors, was previously a consultant for Ocumetics, assisting with regulatory and marketing endeavours. Mr. Burns replaces 
- Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)https://modernod.com/news/viridian-announces-positive-data-from-ongoing-phase-12-trial-evaluating-vrdn-001-in-patients-with-chronic-thyroid-eye-disease-ted/2481716/Viridian Therapeutics announced positive preliminary data from its ongoing phase 1/2 clinical trial of VRDN-001, an investigational full antagonist antibody to the insulin-like growth factor 1 receptor (IGF-1R), in patients with chronic thyroid eye disease (TED). The company also announced an ame
- Jay S. Duker, MD, Named President and CEO of Eyepoint Pharmaceuticalshttps://modernod.com/news/jay-s-duker-md-named-ceo-of-eyepoint-pharmaceuticals/2481715/EyePoint Pharmaceuticals announced the appointment of Jay S. Duker, MD, as President and Chief Executive Officer. Dr. Duker has transitioned from his most recent role as Chief Operating Officer (COO) and President. Dr. Duker has also been appointed to the Board of Di
- Visgenx Announces Positive Results from a Key Translational Study for its Gene Therapy Candidate for Dry AMDhttps://modernod.com/news/visgenx-announces-positive-results-from-a-key-translational-study-for-its-gene-therapy-candidate-for-dry-amd/2481700/Visgenx announced positive data from a non-human primate study. The translational study used a single subretinal injection to deliver VGX-0111 (carrying an ELOVL2 transgene) to investigate whether VGX-0111 expresses in the target tissues and causes an increase in certain very long chain
- UnitedHealthcare Launches Virtual Prescription Renewal Option for Contact Lenses and Glasseshttps://modernod.com/news/unitedhealthcare-launches-virtual-prescription-renewal-option-to-help-members-renew-contact-lenses-and-glasses/2481688/UnitedHealthcare has introduced a new virtual prescription renewal option for the millions of members enrolled in its eligible employer-sponsored vision plans. The renewal option aims to make it more convenient and accessible for plan participants to obtain contact lenses and glasses from th
- FDA Clearance Expands the Label of Eyenuk's EyeArt AI System for the Detection of DRhttps://modernod.com/news/fda-clearance-expands-the-label-of-eyenuks-eyeart-ai-system-for-the-detection-of-dr/2481685/Eyenuk has received FDA clearance to use the Topcon NW400 retinal camera with its EyeArt AI system to automatically detect diabetic retinopathy (DR), adding to the already-cleared usage with Canon CR-2 AF and Canon CR-2 Plus AF cameras. The regulatory clearance of t